Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 16 results.
User Information
Export Records
  1. 1.   Viral, immunologic, and clinical features of primary effusion lymphoma
  2. Lurain, Kathryn; Polizzotto, Mark N.; Aleman, Karen; Bhutani, Manisha; Wyvill, Kathleen M.; Goncalves, Priscila H.; Ramaswami, Ramya; Marshall,Vickie; Miley,Wendell; Steinberg, Seth M.; Little, Richard F.; Wilson, Wyndham; Filie, Armando C.; Pittaluga, Stefania; Jaffe, Elaine S.; Whitby,Denise; Yarchoan, Robert; Uldrick, Thomas S.
  3. Blood. 2019, Apr 18; 133(16): 1753-1761.
  1. 2.   The Effect of Leflunomide on Cycling and Activation of T-Cells in HIV-1-Infected Participants
  2. Read, S. W.; DeGrezia, M.; Ciccone, E. J.; DerSimonian, R.; Higgins, J.; Adelsberger, J. W.; Starling, J. M.; Rehm, C.; Sereti, I.
  3. Plos One. 2010, Aug; 5(8): 7.
  1. 3.   MYH9 Genetic Variants Associated With Glomerular Disease: What Is the Role for Genetic Testing?
  2. Kopp, J. B.; Winkler, C. A.; Nelson, G. W.
  3. Seminars in Nephrology. 2010, Jul; 30(4): 409-417.
  1. 4.   Cycling of gut mucosal CD4+T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels
  2. Ciccone, E. J.; Read, S. W.; Mannon, P. J.; Yao, M. D.; Hodge, J. N.; Dewar, R.; Chairez, C. L.; Proschan, M. A.; Kovacs, J. A.; Sereti, I.
  3. Mucosal Immunology. 2010, Mar; 3(2): 172-181.
  1. 5.   Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4(+) T-Cell Counts
  2. Avidan, N. U.; Goldstein, D.; Rozenberg, L.; McLaughlin, M.; Ferenci, P.; Masur, H.; Buti, M.; Fauci, A. S.; Polis, M. A.; Kottilil, S.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2009 52(4): 452-458.
  1. 6.   Antiretroviral Tissue Kinetics: In Vivo Imaging Using Positron Emission Tomography
  2. Di Mascio, M.; Srinivasula, S.; Bhattacharjee, A.; Cheng, L.; Martiniova, L.; Herscovitch, P.; Lertora, J.; Kiesewetter, D.
  3. Antimicrobial Agents and Chemotherapy. 2009 53(10): 4086-4095.
  1. 7.   The effect of continuous versus pericycle antiretroviral therapy on IL-2 responsiveness
  2. Healey, L. M.; Hahn, B. K.; Rehm, C. A.; Adelsberger, J.; Qin, J.; Follmann, D. A.; Tavel, J.; Kovacs, J. A.; Sereti, I.; Davey, R. T.
  3. Journal of Interferon and Cytokine Research. 2008 28(7): 455-461.
  1. 8.   Mitochondrial DNA haplogroups influence AIDS progression
  2. Hendrickson, S. L.; Hutcheson, H. B.; Ruiz-Pesini, E.; Poole, J. C.; Lautenberger, J.; Sezgin, E.; Kingsley, L.; Goedert, J. J.; Vlahov, D.; Donfield, S.; Wallace, D. C.; O'Brien, S. J.
  3. Aids. 2008 22(18): 2429-2439.
  1. 9.   Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus(mac251)-infected macaques
  2. Hryniewicz, A.; Price, D. A.; Moniuszko, M.; Boasso, A.; Edghill-Spano, Y.; West, S. M.; Venzon, D.; Vaccari, M.; Tsai, W. P.; Tryniszewska, E.; Nacsa, J.; Villinger, F.; Ansari, A. A.; Trindade, C. J.; Morre, M.; Brooks, D.; Arlen, P.; Brown, H. J.; Kitchen, C. M. R.; Zack, J. A.; Douek, D. C.; Shearer, G. M.; Lewis, M. G.; Koup, R. A.; Franchini, G.
  3. Journal of Immunology. 2007, Mar; 178(6): 3492-3504.
  1. 10.   Decreased CD127 expression on T cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapy
  2. Read, S. W.; Higgins, J.; Metcalf, J. A.; Stevens, R. A.; Rupert, A.; Nason, M. C.; Lane, H. C.; Sereti, I.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2006, Aug; 42(5): 537-544.
  1. 11.   IL-15 induces C4+ effector memory T cell production and tissue emigration in nonhuman primates
  2. Picker, L. J.; Reed-Inderbitzin, E. F.; Hagen, S. I.; Edgar, J. B.; Hansen, S. G.; Legasse, A.; Planer, S.; Piatak, M.; Lifson, J. D.; Maino, V. C.; Axthelm, M. K.; Villinger, F.
  3. Journal of Clinical Investigation. 2006, JUN; 116(6): 1514-1524.
  1. 12.   Prednisolone pharmacokinetics in the presence and absence of Ritonavir after oral prednisone administration to healthy volunteers
  2. Penzak, S. R.; Fomnentini, E.; Alfaro, R. M.; Long, M.; Natarajan, V.; Kovacs, J.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005, DEC 15; 40(5): 573-580.
  1. 13.   Endothelial dysfunction in HIV-infected patients on CART does not improve even when lipid profiles improve on pravastatin
  2. Sklar, P. A.; Grubb, J. R.; Voell, J. D.; Zalos, G.; Blackwelder, W. C.; Metcalf, J. A.; Rupert, A.; Gladwin, M. T.; Witek, J.; Davey, R. T.; Masur, H.; Cannon, R. O.
  3. Antiviral Therapy. 2004, DEC; 9(6): L15-L15.
  1. 14.   CpG oligodeoxynucleotides improve the response to hepatitis B immunization in healthy and SIV-infected rhesus macaques
  2. Verthelyi, D.; Wang, V. W.; Lifson, J. D.; Klinman, D. M.
  3. Aids. 2004 18(7): 1003-1008.
  1. 15.   Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study
  2. Yamashita, T. E.; Phair, J. P.; Munoz, A.; Margolick, J. B.; Detels, R.; O'Brien, S. J.; Mellors, J. W.; Wolinsky, S. M.; Jacobson, L. P.
  3. Aids. 2001 15(6): 735-746.
  1. 16.   High-level resistance to 3 '-azido-3 '-deoxythimidine due to a deletion in the reverse transcriptase gene of human immunodeficiency virus type 1
  2. Imamichi, T.; Sinha, T.; Imamichi, H.; Zhang, Y. M.; Metcalf, J. A.; Falloon, J.; Lane, H. C.
  3. Journal of Virology. 2000 74(2): 1023-1028.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel